Stay updated on HER2/EGFR Mutant Tumors Clinical Trial
Sign up to get notified when there's something new on the HER2/EGFR Mutant Tumors Clinical Trial page.

Latest updates to the HER2/EGFR Mutant Tumors Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.0%

- Check28 days agoChange DetectedA banner announces upcoming changes to NIH websites and notes that agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.3%

- Check35 days agoChange DetectedThe site footer revision advances from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check42 days agoChange DetectedThe site revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check63 days agoChange DetectedThe record history now shows Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates a software version update for the history view rather than any changes to study data or text.SummaryDifference0.0%

Stay in the know with updates to HER2/EGFR Mutant Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HER2/EGFR Mutant Tumors Clinical Trial page.